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ABSTRACT The architecture and structural mechan-
ics of the cell nucleus are defined by the nuclear
lamina, which is formed by A- and B-type lamins.
Recently, gene duplication and protein overexpression
of lamin B1 (LB1) have been reported in pedigrees with
autosomal dominant leukodystrophy (ADLD). How-
ever, how the overexpression of LB1 affects nuclear
mechanics and function and how it may result in
pathology remain unexplored. Here, we report that in
primary human skin fibroblasts derived from ADLD
patients, LB1, but not other lamins, is overexpressed at
the nuclear lamina and specifically enhances nuclear
stiffness. Transient transfection of LB1 in HEK293 and
neuronal N2a cells mimics the mechanical phenotype
of ADLD nuclei. Notably, in ADLD fibroblasts, reduc-
ing LB1 protein levels by shRNA knockdown restores
elasticity values to those indistinguishable from control
fibroblasts. Moreover, isolated nuclei from ADLD fi-
broblasts display a reduced nuclear ion channel open
probability on voltage-step application, suggesting that
biophysical changes induced by LB1 overexpression
may alter nuclear signaling cascades in somatic cells.
Overall, the overexpression of LB1 in ADLD cells alters
nuclear mechanics and is linked to changes in nuclear
signaling, which could help explain the pathogenesis of
this disease.—Ferrera, D., Canale, C., Marotta, R.,
Mazzaro, N., Gritti, M., Mazzanti, M., Capellari, S.,
Cortelli, P., Gasparini, L. Lamin B1 overexpression
increases nuclear rigidity in autosomal dominant leuko-
dystrophy fibroblasts. FASEB J. 28, 3906–3918 (2014).
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The nuclear lamina is the filamentous meshwork that
underlies the inner nuclear membrane of eukaryotic cells.
It has unique elastic and compressibility properties and
appears to act as a molecular shock absorber (1, 2), with
behavior that is typical of a solid-elastic shell. Lamin B1
(LB1) is a major component of the nuclear lamina and,
together with other lamins (e.g., lamin A/C), plays a
role in the structure and function of the nucleus (3).
Over the past few decades, mutations in lamin A (LA)
and lamin-associated proteins have been shown to
cause various human diseases. These diseases are
termed laminopathies and include Emery-Dreifuss and
limb-girdle muscular dystrophies, dilated cardiomyop-
athy, Dunningan-type familial partial lipodystrophy,
Charcot-Marie tooth disorder type 2, and Hutchison-
Gilford progeria syndrome (4).
The role of LB1 in pathological conditions was discov-
ered only recently, when the duplication of the gene
encoding this protein was associated with adult-onset
autosomal dominant leukodystrophy (ADLD) (5–7).
ADLD is the first identified laminopathy that affects the
central nervous system and is characterized by widespread
cerebral demyelination (8–12), as well as autonomic and
pyramidal symptoms (13). Pathogenesis may be linked to
altered mechanical properties of the nucleus. Changes in
other lamins alter the nuclear lamina and affect the
structural integrity of the nucleus and its sensitivity to
mechanical stress. For example, lamins A and C (LA/C)
play a key role in defining the nuclear lamina’s elastic
properties: LA/C-deficient cells have increased numbers
of misshapen nuclei and reduced nuclear stiffness (14).
Moreover, when wild-type (15) or mutant LA is overex-
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pressed (16), the stiffness of Xenopus oocyte nuclei in-
creases proportionally to the LA concentration.
Unlike LA/C, the contribution of LB1 to the elastic
properties of the nucleus is unclear. In LB1-deficient
mouse embryonic fibroblasts (MEFs), although nuclei
respond normally to biaxial strain, there are severe
abnormalities in nuclear morphology (14). However, it
remains unclear whether the pathological overexpres-
sion of LB1 that is associated with ADLD alters nuclear
mechanics and function in somatic cells.
To address this central question, we examined how
LB1 impacts nuclear rigidity and function, using pri-
mary cultures of human skin fibroblasts derived from
patients with ADLD bearing a duplication of the LB1
gene. Overexpressed LB1 is primarily localized to the
nuclear lamina and results in increased nuclear stiff-
ness. In HEK293 and neuronal N2a cells, the overex-
pression of LB1 significantly increases nuclear rigidity,
mimicking the mechanical phenotype of ADLD nuclei.
When LB1 expression is reduced in ADLD fibroblasts
via LB1 shRNA, nuclear stiffness reverts to levels indis-
tinguishable from those of control (CTR) fibroblasts.
Further, in nuclei isolated from ADLD fibroblasts,
while single channel conductance is preserved, the
open probability of the ion channel is reduced with
increasing voltage steps. This suggests that, in somatic
cells, LB1 overexpression causes biophysical changes in
the nuclear lamina that alter nuclear signaling, possibly
leading to nuclear dysfunction in ADLD.
MATERIALS AND METHODS
Patients with ADLD and CTR subjects
Skin biopsies were obtained from 2 affected ADLD patients
carrying LB1 gene duplications (17), 6 noncarrier siblings,
and 6 healthy volunteers who were age matched with patients
at the Neurological Clinic of the University of Bologna. The
study has been approved by the AUSL Bologna Ethical
Committee, and informed consent was obtained from all of
participants. The clinical features of the patients were as
follows. At 48 yr of age, the index patient reported micturi-
tion urgency and impotence followed by progressive asthenia,
objective vertigo, orthostatic syncope, constipation, and mo-
tor difficulties of the left lower limb with poor balance.
Neurological examination revealed spinal and cerebellar
signs and a severe symptomatic orthostatic hypotension. His
57 yr old sister was examined following a 7 yr history of slowly
progressive clumsy gait and urinary urgency. Neurological
examination revealed cerebellar signs. Cardiovascular re-
flexes revealed borderline results. In both patients, the brain
MRI revealed a diffuse T2 hyperintensity of the cerebral white
matter with a predominant frontoparietal distribution.
The CTR subjects (mean agesd, 52.174.45) and non-
carrier siblings (mean agesd, 36.832.86) did not present
relevant pathologies.
Primary cultures of human skin fibroblasts
The primary cultures of human skin fibroblasts were estab-
lished as described previously (18). For the atomic force
microscopy (AFM) studies, the fibroblasts were analyzed at 4
d of proliferation in complete medium (proliferating cells) or
following serum deprivation for 24 h (quiescent cells). In
selected experiments, the cells were reexposed to complete
medium following serum deprivation for 1–5 d to test the
reversibility of the quiescent state.
Proliferation ssays
The fibroblasts were plated at 300,000 cells per 75 cm2 flasks.
The cells were harvested weekly by trypsinization and counted
using a hemocytometer. The population doubling (PD) was
calculated using the following equation: PD  log(Nh/
Ns)log2, where Nh is the number of harvested cells and Ns is
the number of seeded cells.
For the bromodeoxyuridine (BrdU) incorporation assays,
the cells were plated onto poly-l-lysine-coated glass coverslips,
exposed to 10 M BrdU for 6 h, and fixed for 30 min in 4%
paraformaldehyde (PFA) in PBS (pH 7.4). The BrdU immu-
nocytochemistry was performed as described previously, with
minor modifications (19). The nuclei were counterstained
with Hoechst-33342 and imaged using a Nikon Eclypse 80i
upright microscope that was equipped with a CFI planAPO
VC 20 times] A.N. 0.80 d.l. 1 mm objective lens and a digital
DS-5 Mc CCD camera (Nikon). BrdU-positive nuclei were
counted and expressed as a percentage of total nuclei.
MEF and HEK293 cell cultures
LB-null (LB1/) mice (20) were obtained from the Mutant
Mouse Regional Resource Center (MMRRCl University of
California, Davis, CA, USA). Animal health and comfort were
veterinary controlled. The mice were housed in filtered cages
in a temperature-controlled room with a 12:12 h dark/light
cycle with ad libitum access to water and food. All of the
animal experiments were performed in accordance with the
European Community Council Directive dated November 24,
1986 (86/609/EEC) and were approved by the Italian Minis-
try of Health and by the IIT Ethical Committee. MEFs were
isolated from wild-type LB/ homozygous and LB1/
embryos at 13.5 d of gestation. The cells were isolated by
digestion in 0.25% Trypsin-EDTA (Invitrogen, Carlsbad, CA,
USA) and 40 g/ml DNase I at 37°C for 1 h and mechanical
dissociation. The fibroblasts were cultured at 37°C in a
humidified incubator with 5% CO2. The offspring genotypes
were determined using primers specific for the wild-type lb1
allele (forward, 5=-TCCGTGTCGTGTGGTAGGAGG-3=; and
reverse, 5=-GCAGGAGGGTTGGGAAAGCC-3=) and for the
mutant allele carrying the gene-trap insertion (forward, as
above; reverse, 5=-CACTCCAACCTCCGCAAACTC-3=). The
genotype was confirmed by Western blot analysis of fibroblast
protein extracts.
HEK293 cells were cultured in DMEM with 4.5 g/l glucose
that was supplemented with 10% FCS and antibiotics. Neuro-
nal N2a cells were cultured as described previously (21).
Plasmids, transfection, and cell sorting
The pCAGGS-LB1-IRES-EGFP plasmid was obtained by clon-
ing human LB1 cDNA (NM_005573.3) into the pCAGGS-
IRES-EGFP vector (22), kindly donated by Dr. L. Cancedda
(Istituto Italiano di Tecnologia, Genova, Italy). LB1 shRNA
and scrambled shRNA plasmids containing the enhanced
green fluorescent protein (EGFP) reporter were a kind gift
from Dr. R. Goldman (Northwestern University, Chicago, IL,
USA). The construction of the shRNA expression plasmids
was described elsewhere (23, 24). The target sequences for
LB1 silencing were as follows: LB1 T3, 5=-CGAGCATCCT-
CAAGTCGTA-3= (human LB1); LB1 T4, 5=-GAATCAGAGGC-
GAGTAGTA-3= (human LB1); and Neg-ctrl, 5=-ATGTACT-
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GCGCGTGGAGA-3= (negative control, scrambled). The loop
sequence is 5=-TTCAAGAGA-3=.
Lipofection (Lipofectamine; Invitrogen) or the Amaxa
Nucleofector device (Lonza, Basel, Switzerland) was used to
transfect subconfluent HEK293 cells and ADLD human skin
fibroblasts, respectively (19). Forty-eight to 72 h later, the
transfected cells were sorted by EGFP expression in FACSFlow
buffer using the BD FACS Aria II Cell Sorter [fluorescence-
activated cell sorting (FACS); Becton Dickinson, Franklin
Lakes, NJ, USA] at a pressure of 3100 mbar and an aspiration
rate of 10 l/min. The nuclei were extracted from EGFP-
positive cells and were analyzed using AFM.
Flow cytometry analysis
For the DNA content analysis, the fibroblasts were detached
by trypsinization and incubated on ice for 10 min with 50
g/ml propidium iodide in 0.1% sodium citrate, 0.1 mg/ml
RNase A, and 0.1% Triton X-100. The cells were immediately
analyzed using flow cytometry using the BD FACS Aria II Cell
Sorter with FACSDiva software.
Antibodies and reagents
The following primary antibodies were used: mouse mono-
clonal antibodies against LB1 (Zymed, San Francisco, CA,
USA); LB2 (Abcam, Cambridge, MA, USA); LA/C (Millipore,
Billerica, MA, USA); rabbit polyclonal antiserum against LB1
(Abcam); LA/C (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), trimethyl histone H3 (Lys27) (Millipore); -tubulin,
-tubulin and -actin (Sigma, St. Louis, MO, USA); and
BU1/75 (ICR1) rat monoclonal anti-BrdU antibody (Ab-
cam). To analyze the localization of nuclear components,
the following primary antibodies were used: anti-Nup153
(Abcam), anti-nuclear pore complex (mab 414; Covance,
Princeton, NJ, USA), anti-sc-35 (Sigma), anti-LAP2 (BD
Biosciences, San Diego, CA, USA), and anti-fibrillarin
(Cytoskeleton Denver, CO, USA) mouse monoclonal anti-
bodies, as well as antiactivated RNA Polymerase II mono-
clonal IgM (Covance).
For the Western blot analysis, horseradish-peroxidase-con-
jugated secondary antibodies (Bio-Rad Laboratories, Hercu-
les, CA, USA) were used for detection. For the immunofluo-
rescence analyses, Alexa fluorophore-conjugated anti-mouse,
anti-rabbit, or anti-rat antibodies from Invitrogen were used.
Unless otherwise specified, the general reagents and chem-
icals were from Sigma, and the reagents for the cell cultures
were from Invitrogen.
Western blot analysis
Confluent fibroblast monolayers were lysed by boiling for 5
min in 1% SDS, 1 mM EDTA, 5 mM HEPES (pH 7.4), and
protease inhibitors. The cells were then sonicated and spun at
20,000 g for 20 min at room temperature (RT). Equal
amounts of proteins were separated on NuPage 10% bis-tris
polyacrylamide gels (Invitrogen) and were analyzed by West-
ern blotting, as described previously (25), using the antibod-
ies listed above. Densitometric analysis was performed using
the U.S. National Institutes of Health (NIH) ImageJ program
(26). The protein levels were expressed as a ratio with respect
to - or -tubulin levels and normalized to CTR protein
expression.
Salt extraction
The salt extraction of nuclei was performed as previously
reported (27), with minor modifications. Briefly, the nuclei
were extracted from serum-deprived confluent monolayers by
osmotic lysis and were washed in 10 mM Tris HCl pH 7.4, 2
mM MgCl2, and 0.1% Triton X-100. Sequential extraction was
then performed with 50 mM and 500 mM NaCl. At each step,
the nuclei were incubated for 5 min in extraction buffer on
ice and then spun at 700 g for 5 min at 4°C. The final pellet
that contained the insoluble fraction was lysed in 1% SDS, 1
mM EDTA, 5 mM HEPES (pH 7.4), and protease inhibitors
by boiling and sonication. The fractions were analyzed by
Western blot, as described above.
Immunofluorescence
The fibroblasts were plated onto poly-L-lysine-coated cover-
slips, serum-deprived for 24 h, fixed in 4% PFA, and immu-
nolabeled as described previously (25, 28).
To count the nuclei with irregular morphology, the sam-
ples were immunostained using rabbit polyclonal anti-LB1 or
goat anti-LB and counterstained with Hoechst-33342. The
confocal optical sectioning was performed at RT using a Leica
TCS SP5 AOBS TANDEM inverted confocal microscope that
was equipped with a HCX PL APO 40 	1.25 Oil and a HCX
PL APO 
 blue 63 	1.4 NA Oil objective lenses. The nuclei
were scored as normal (oval or spherical shape) or as
misshapen (irregular contour, the presence of blebs and
membrane invaginations) by an operator who was blind to
the nature of the samples. The count of RNA polymerase
II-positive nuclei was performed on confocal images of blind-
coded samples immunostained for RNA polymerase II by an
experienced researcher. To quantify protein levels, z-stack
confocal images of ADLD and CTR nuclei were acquired
alongside in the same confocal session using fixed laser and
scanning settings. With the use of maximal projection confo-
cal images, nuclei were selected and the protein immunore-
active area was measured using the Leica LAS and the NIH
ImageJ softwares (26). Data are normalized on the area
covered by DNA staining with the Hoechst-33342 dye.
Immunoelectron microscopy
CTR and ADLD fibroblasts were fixed for 1 h at RT in 0.2%
glutaraldehyde and 2% paraformaldehyde in culture medium
and processed for cryosectioning, as described previously
(29). Briefly, following fixation, the cells were repeatedly
washed in 0.15% glycine in PBS, resuspended in 12% gelatin,
and cryoprotected overnight at 4°C in 2.3 M sucrose. The
sections were mounted on cryo-pins and snap-frozen in liquid
nitrogen. Ultrathin 72 nm thick cryosections were cut at
120°C using a Cryo Immuno diamond knife (Diatome) on
a Leica EM UC6 cryoultramicrotome and placed on Formvar
nickel-coated grids. For the immunostaining, the sections
were blocked in 1% BSA in PBS and labeled with rabbit
polyclonal anti-LB1 antibody (1: 50). The sections were then
stained with a secondary anti-rabbit antibody conjugated to
10-nm colloidal gold (GAR Aurion, Delta Microscopie). The
immunodecorated sections were stained with 2% uranyl
acetate and embedded in a 9/1 mixture of methylcellulose/
saturated uranyl acetate. Transmission electron microscopy
images were collected using a Jeol JEM 1011 microscope
operating at 100 KV and recorded with an 11 Mp Gatan Orius
SC100 Charge-Coupled Device camera. The LB1 levels both
at the nuclear lamina (within 30 nm from the inner nuclear
membrane) and in the nucleoplasm were evaluated by count-
ing the number of gold particles on a total of 88 randomly
sampled micrographs (43 from CTR and 45 from ADLD
fibroblasts), corresponding to a total nuclear area 130 m2.
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AFM analysis
To avoid confounding effects of cytoskeletal components and
force dissipation by cytosolic factors, we performed AFM
indentation on isolated nuclei that were extracted by osmotic
lysis of cells with 0.56% KCl for 30 min at RT and spun at 350
g for 5 min at RT. The nuclei were then resuspended in PBS
and plated onto a poly-L-lysine-coated Petri dish by incuba-
tion for 1 h at RT. In CTR experiments, we performed AFM
indentation on isolated CTR nuclei placed in PBS or in a
buffer (Cyt) mimicking cytosolic ionic content containing 10
mM HEPES, 150 mM NaCl, 3 mM KCl, 22 mM sucrose, 10
mM glucose, 1 mM MgCl2, and 2 mM CaCl2 at pH 7.4 (30).
Stiffness values were similar in the 2 experimental conditions
(PBS, 1.710.20 mN/m, n11; Cyt, 1.530.14, n12;
P0.46, Student’s t test). Therefore, PBS was used for AFM
indentation on isolated nuclei throughout the study.
In selected experiments, we also carried out AFM indentation
on adherent quiescent living cells. Fibroblasts or N2a cells were
plated onto 40 mm petri dishes (TPP Techno Plastic Products,
Switzerland), serum deprived and/or transfected as described
above. Throughout AFM indentation measurements, cells were
maintained at 37°C in a live imaging buffer containing 10 mM
HEPES, 150 mM NaCl, 3 mM KCl, 22 mM sucrose, 10 mM
glucose, 1 mM MgCl2, and 2 mM CaCl2 at pH 7.4 (31).
AFM indentation (32–34) was performed using the Nanowiz-
ard II AFM (JPK Instruments, Berlin, Germany) that was
mounted on an Axio Observer D1 inverted optical microscope
(Carl Zeiss, Oberkochen, Germany). The acquisition of force
curve maps required 5 min per nucleus or cell. On average,
6–9 maps were acquired in each experimental session. Nuclear
elasticity was probed using spherical polystyrene beads (Ø 4 m;
Polysciences, Inc., Warrington, PA USA) that were mounted on
silicon tipless cantilevers TL1 (Nanosensors, Neuchatel, Switzer-
land) with nominal spring constant of 0.03 N/m. The actual
spring constant of each cantilever was determined using the in
situ thermal noise method (35). The maximum force applied to
the sample was 1 nN. The velocity of the piezo-scanner was
maintained at a constant 3 m/s. The force curves were
corrected for the bending of the cantilever (36) to calculate the
tip-sample separation and to build force vs. indentation (F-I)
curves (Supplemental Fig. S1). Nuclear stiffness was computed
as described (15) by calculating the linear fit of the F-I curve
between 2 specific force values (i.e., Fo250 pN and F1550
pN), corresponding to indentations of1 m. The force curves
were analyzed using a custom MATLAB routine to allow the
batch processing of a set of curves according to the following
formula:
Stiffness mN ⁄ m  
Y1  Y0
X1  X0
where X1 and X0 are the tip-sample separation in m and Y1
and Y0 are the deflection in nN at forces of F1 and F0,
respectively (Supplemental Fig. S1). A total of 593 nuclei were
analyzed. Eight-by-eight curve point force indentation maps
(64 curves/nucleus) covering an area of 16 m2 were ac-
quired in the center of each nucleus using the DirectOverlay
routine of the AFM acquisition software (JPK Instruments).
Calculated stiffness values were typically comprised between
0.05 and 10 mN/m, with only a minor proportion (5%)
exceeding these limits. Nuclear integrity following AFM anal-
ysis was confirmed using propidium iodide exclusion and
map repetition on the same nucleus (Supplemental Fig. S1).
The Young’s elastic modulus (E) was calculated as described
previously (37). Briefly, E was calculated by converting the
force-displacement (F-D) curves into F-I curves and fitting them
with the Hertz model, taking the Poisson ratio of the nucleus to
be 0.5, which is typical for soft biological materials (33). The
Hertz contact mechanics model can be directly applied to
examine thin samples when the indentation depth is 10% of
the sample thickness (37, 38). Therefore, to determine the
correct indentation range, we reconstructed sample topography
(Supplemental Fig. S2A) and calculated E for different inden-
tation depths (Supplemental Fig. S2B-D). When the indenter
contacts the nuclear surface, E rose sharply up to plateau values,
which represent the Young’s elastic modulus of the nucleus.
Further increases in indentation (i.e., indentation higher than
1.2  0.2 m; Supplemental Fig. S2B) caused an additional
increase in E due to mixed contributions from both the nucleus
and the substrate. Consistent with previous findings (37), com-
parable distributions of E were obtained when indentations 1
m were used (Supplemental Fig. S2C). However, the E-fre-
quency distribution shifted to higher values when the indenta-
tion depth increased to 1.5 m (Supplemental Fig. S2D), likely,
because of contribution of substrate stiffness or nonlinear be-
havior of nuclei due to chromatin or biopolymer networks.
Thus, throughout the analyses, an indentation depth1m was
considered.
To verify whether 1 m indentation was comprised within
the recommended limits for the Hertz model application
(i.e., 10% of sample thickness), we reconstructed nuclear
topography by force mapping (Supplemental Fig. S2A) (34,
39) and determined the maximum nuclear thickness. A
collection of F-D curves was acquired on a matrix of 40 	 40
points that were equally distributed on a 30 	 30 m2 square
area. Silicon nitride triangular cantilevers with pyramidal tips,
a 20 nm nominal tip radius and typical elastic constant of 0.06
N/m were used (NP; Bruker Corporation, Billerica, MA,
USA). A maximal force of 0.20 nN was applied. The sample
topography was reconstructed from the analysis of the canti-
lever deflection and corrected for the indentation depth that
was calculated for each point of the map. The maximum
height of fibroblast nuclei was calculated on the peak cross-
section of the AFM topography. Isolated nuclei appear as
spherical caps with a high curvature radius due to the
interaction with the substrate. The maximum nuclear thick-
ness of nuclei that were extracted from CTR fibroblasts was
12.35  0.33 m (n19 nuclei) and was constant in the
surrounding area (8.85% variance at 2 m from the
maximum). The maximum indentation depth of 1 m rep-
resents 8% of the sample thickness and is within the values
recommended for the Hertz model (37).
Patch-clamp recordings
Nuclei were isolated by osmotic lysis as described above. The
nuclear pellet was resuspended in 1 ml of external solution
and kept on ice until plating. Patch-clamp recordings were
performed on isolated nuclei using standard methods (40,
41). In brief, the patch electrodes were pulled from hard
borosilicate glass (Heidelberg, Germany) on a Brown-Flam-
ing P-87 puller (Sutter Instruments, Novato, CA, USA). The
pipettes were fire polished to an external tip diameter of
1–1.5 m and 7–10 M electrodes resistance. We applied the
standard patch-clamp technique to obtain nucleus-attached
patches between 20 and 50 G in resistance. The external
solution was also used to fill the recording patch-clamp
electrode and was composed by the following (in mM): 120
KCl, 2 MgCl2, 0.1 CaCl2, 1.1 EGTA (final Ca
2 concentration
of 104), and 10 HEPES at pH 7.4. An Axopatch 200 B
amplifier and PClamp 9 (both from Molecular Devices,
Sunnyvale, CA, USA) were used to record and analyze the
single channel currents. Current recordings were digitized at
5 KHz and filtered at 1000 Hz.
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Statistical analysis
The statistical analysis between the groups with normal distribu-
tions was performed using Student’s t test for 2 groups or
ANOVA for multiple comparisons. When the normality test
failed, the analysis was performed using nonparametric tests,
such as the Mann-Whitney rank sum test or Kruskal-Wallis 1-way
ANOVA on ranks followed by a post hoc Dunn’s test. The
differences between groups were considered to be statistically
significant when P 0.05. Data throughout the text are reported as
average values  se, except when otherwise specified.
RESULTS
LB1 is overexpressed in ADLD fibroblasts
We first analyzed LB1 expression in skin fibroblasts
from ADLD patients who carry a duplication of the LB1
gene, siblings without this duplication, and age-
matched healthy volunteers. LB1 expression was similar
in fibroblasts from healthy volunteers and noncarrier
siblings (LB1/tubulin ratio, average in healthy volun-
teers: 1.000.20; noncarrier siblings: 0.960.22; P
0.46, Student’s t test), which were therefore pooled as
CTRs. Compared with these CTRs, fibroblasts from
ADLD patients exhibited normal levels of the cognate
proteins LB2, LA, and LC but significantly overex-
pressed LB1 (Fig. 1A–C).
We next investigated whether the subcellular local-
ization of LB1 is altered in ADLD cells. We found that
LB1 is correctly localized to the nuclear lamina and the
nucleoplasm in both ADLD and CTR nuclei (Fig. 1C).
However, immunofluorescence and immunoelectron
microscopy revealed that in ADLD nuclei, LB1 immu-
noreactivity is significantly increased in both the nu-
clear lamina and the nucleoplasm (Fig. 1C-E). Clusters
of gold particles were frequently observed underneath
the nuclear envelope of ADLD, but not CTR, nuclei,
indicating that the overexpressed protein had accumu-
lated in foci (Fig. 1D, inset). Consistent with the EM
data (Fig. 1D, E), the sequential biochemical extraction
of nuclear proteins with increasing salt concentration
revealed that the majority of LB1 was in the insoluble
fraction of both CTR and ADLD fibroblasts, indicating
that LB1 primarily associates with the nuclear lamina
(Supplemental Fig. S3A). In ADLD fibroblasts, the level
of LB1 in the insoluble fraction was significantly higher
than that in CTR cells (Supplemental Fig. S3A). Over-
all, these experiments indicate that overexpressed LB1
mainly localizes to the nuclear lamina, where it accu-
mulates in foci.
Figure 1. LB1 was overexpressed in ADLD primary human skin fibroblasts. LB1 protein expression was analyzed in primary
human skin fibroblasts that were derived from patients with ADLD and CTR subjects. A) Representative Western blots of LB1
and LA/C in fibroblast total lysates. -Tubulin was used as the loading CTR. B) Quantitative analysis of LB1, LB2, and LA/C
expression levels. The data are normalized to -tubulin and expressed as percentages of CTR levels. The bars represent the mean
se. of 3–6 independent experiments. *P  0.05, Student’s t test. C) Representative maximal projections of z-stack confocal
images of nuclei from CTR and ADLD human skin fibroblasts immunostained for LB1. Scale bar  5 m. D) Representative
immunoelectron microscopy images from CTR (left panel) and ADLD (right panel) nuclei immunodecorated for LB1. Arrows
and arrowheads indicate gold particles at the nuclear lamina and in the nucleoplasm, respectively. In the inset, the 2 arrows
indicate a cluster of immunogold particles at the nuclear envelope of one ADLD nucleus. Cyt  cytosol; M  mitochondrion;
Nu  nucleus. Scale bars  200 nm. E) Semiquantitative analysis of the density of gold particles detected at the nuclear lamina
and nucleoplasm of CTR and ADLD nuclei. Values represent the mean  se. **P  0.01, Student’s t test.
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LB1 overexpression does not affect cell proliferation
in ADLD fibroblasts
Cell proliferation can affect nuclear mechanics (33),
and LB1 expression levels regulate the cell prolifera-
tion rate in lung embryonic fibroblasts (23, 42) and
human dermal fibroblasts (43). We therefore first
examined whether LB1 overexpression was associated
with altered proliferation in ADLD fibroblasts. The PD
over 20 passages in vitro was similar in primary fibro-
blasts from CTR subjects (P0.706, 1-way ANOVA,
n6) and those from ADLD patients (P0.801, 1-way
ANOVA, n2; Supplemental Fig. S3C). Consistently,
the average PD and doubling time (DT) of CTR and
ADLD fibroblasts were comparable. The average PD in
CTR fibroblasts was 1.38  0.57; in ADLD fibroblasts,
1.47 0.51 (P0.494, Student’s t test). The average DT
of CTR fibroblasts was 6.34  3.71 d; ADLD fibroblasts,
5.84  3.56 d (P0.544, Mann-Whitney rank sum test).
Overall therefore, ADLD fibroblasts had no obvious
proliferation abnormalities.
To investigate how ADLD fibroblasts adapt their
proliferative potential to changes in environmental
growth factors, we assessed their ability to enter quies-
cence on serum withdrawal for 24 h. Serum deprivation
for 24 h caused a significant reduction in BrdU incor-
poration in both CTR and ADLD fibroblasts, indicating
a quiescent phenotype. The percentage of BrdU-posi-
tive cells in proliferating and quiescent conditions was
comparable in CTR and ADLD fibroblast cultures
(Supplemental Fig. S3D), confirming their equal pro-
liferative features. Notably, the quiescent state could be
reversed by reexposing the cells to serum-containing
medium for 24 h, even after prolonged (5 d) serum
withdrawal. Indeed, after 5 day serum deprivation, 4.80 
1.30% of CTR cells and 1.57  0.02% of ADLD cells
were BrdU positive, consistent with a quiescent state.
Reexposing such quiescent cells to serum for 24 h
increased the proportion of BrdU-positive cells to 34.96 
5.01% in CTR cells and 33.33  8.2% in ADLD cells,
indicating the absence of senescence in both CTR and
ADLD cultures. Overall, these results indicate that
ADLD fibroblasts normally adapt to the absence of
growth stimuli by entering a quiescent state, without
undergoing senescence.
LB1 overexpression increases nuclear rigidity in
ADLD human skin fibroblasts
We next aimed to determine whether LB1 overexpres-
sion in ADLD cells affects the elastic properties of the
nucleus. A cell’s mechanical properties (33, 44) and
LB1 levels (45) vary during the cell cycle. It is therefore
also possible that the mechanical properties of isolated
nuclei differ according to a cell’s proliferative state. To
test this and thus define the optimal proliferative state
for nuclear stiffness analysis, we performed AFM inden-
tation on intact nuclei isolated from CTR proliferating
or quiescent fibroblasts. Nuclei from proliferating cells
displayed a broader probability distribution of stiffness
values [95% confidence Interval, CI: 0.253.55 mN/m;
Fig. 2A] than nuclei from quiescent fibroblasts (95%
CI: 0.252.05 mN/m; Fig. 2B). Moreover, nuclei from
proliferating cells displayed a bimodal distribution,
indicating that there is a subpopulation of cells with
lower elastic modulus, likely the cells in G1/S (P1
population of flow cytometry data; Fig. 2A, inset).
Further, the average stiffness of proliferating nuclei was
significantly higher than that of quiescent nuclei (Fig.
2C). These results indicate that the nuclear mechanics
change with a cell’s proliferative state.
We also tested whether nuclear stiffness varies with
aging in culture by analyzing quiescent CTR fibroblasts
at different passages. We observed no significant differ-
ences in the calculated stiffness values at passages 4–16.
The mean stiffness at passage 4 was 0.71  0.08 mN/m
(n4); at passage 8, 0.76  0.10 mN/m (n21); and at
passage 16, 0.57 0.16 mN/m (n7; P0.311, Kruskal-
Wallis 1-way ANOVA on ranks), indicating that aging in
vitro 16 passages does not affect nuclear stiffness.
Based on these results, to reduce the intrinsic variability
and exclude confounding effects arising from cell cycle
stages, ADLD and CTR nuclear rigidity was analyzed in
nuclei isolated from quiescent fibroblasts within 16
passages.
Figure 2. Nuclear stiffness of human skin fibroblasts varied with the cell proliferation state. AFM nuclear stiffness analysis was
performed on nuclei that were extracted from proliferating (A) and quiescent CTR human skin fibroblasts (B). A, B) Stiffness
distribution calculated from F-I curves; y-axis: relative frequency values (0f1); x-axis: stiffness bins (0.1 mN/m). The insets
in A and B show the FACS analysis of propidium iodide-labeled fibroblasts, indicating that the majority of cells are in G1/S
phases (P1) in quiescent cells (B). C) Box plot of average nuclear stiffness values. A total of 65 nuclei of proliferating (n31)
and quiescent (n34) fibroblasts were analyzed in 2 independent experimental sessions. **P  0.01, Mann-Whitney rank sum
test.
3911LB1 LEVELS MODULATE NUCLEAR RIGIDITY
The nuclear stiffness values in ADLD nuclei had a
broader frequency distribution than those of CTR
nuclei (95% CI, CTR 0.151.45 mN/m; ADLD:
0.253.45 mN/m) (Fig. 3A). The majority of ADLD
nuclei (77%) showed stiffness values higher than the
median CTR stiffness value (Fig. 3B). Moreover, the
median nuclear stiffness was significantly higher in
ADLD nuclei than CTR nuclei (Fig. 3C). Consistent
with this, the Young’s elastic modulus (E) of ADLD
nuclei was 2.7-fold higher than CTR nuclei (CTR,
236.6816.33 Pa, n191; ADLD, 644.0665.07 Pa,
n100; P  0.01, Student’s t test). To explore whether
nuclear stiffness displays a similar behavior in living
cells, we performed AFM indentation on adherent
living CTR and ADLD fibroblasts in quiescent condi-
tions. The nuclear stiffness of living fibroblasts was
6-fold higher than that of isolated nuclei, suggest-
ing significant contributions from adhesive forces,
the underlying cytoskeleton, and cytosolic factors to
the measurement. Consistent with results on isolated
nuclei, we found that the nuclear stiffness was signif-
icantly increased in living ADLD fibroblasts (Fig.
3D-F). In fact, ADLD living fibroblasts had a broader
frequency distribution of nuclear stiffness values
than CTR nuclei (Fig. 3D). The majority of ADLD
fibroblasts (81%) showed nuclear stiffness values
higher than the median CTR stiffness value (Fig. 3E)
and the average nuclear stiffness was significantly
increased (73%) in ADLD nuclei (Fig. 3F). Overall,
these results indicate that in somatic cells from
ADLD patients, pathological LB1 overexpression is
linked to increased nuclear rigidity.
ADLD-associated increased nuclear rigidity is
dependent on LB1 overexpression
To test whether LB1 regulates nuclear mechanics, we
next examined whether transient LB1 overexpression
mimics the pathological phenotype of ADLD and in-
creases nuclear rigidity. Using lipofection, we trans-
fected HEK293 cells with bicistronic expression vectors
containing cDNA for LB1 plus an EGFP reporter or the
EGFP reporter alone (Fig. 4A). EGFP-positive cells were
isolated 48 h later by FACS, and the nuclei were
extracted for AFM analysis. Nuclear stiffness was signif-
icantly higher in nuclei overexpressing both LB1 and
EGFP compared with nuclei expressing EGFP alone,
displaying a 70% increase in the median stiffness (Fig.
4B). To confirm this result in disease target cells, we
tested if LB1 overexpression in neuronal cells caused a
Figure 3. Nuclear stiffness was increased in ADLD human skin fibroblasts. AFM nuclear stiffness analysis was performed on
extracted fibroblast nuclei (A-C) or living quiescent CTR and ADLD fibroblasts (C, D). A) Representative stiffness
distributions that were calculated from the F-I curves of nuclei from fibroblasts of one CTR (black) and one ADLD (gray)
patient; y-axis: relative frequency values (0f1); x-axis, stiffness bins (0.1 mN/m). B) Average calculated stiffness of nuclei
from fibroblasts of 2 CTR subjects (black symbols) and 2 patients with ADLD (gray symbols). Each symbol represents the
average stiffness  sd of 1 nucleus. C) Box plot of average nuclear stiffness values of CTR and ADLD fibroblasts. A total
of 291 fibroblast nuclei from 6 CTR subjects (n191 nuclei) and 2 ADLD (n100 nuclei) patients were analyzed in 3– 6
independent experimental sessions. **P  0.01, Mann-Whitney rank sum test. D) Representative stiffness distributions that
were calculated from the F-I curves of living fibroblasts of 1 CTR (black) and 1 ADLD (gray) patient; y-axis: relative
frequency values (0f1); x-axis: stiffness bins (0.1 mN/m). E) Average calculated stiffness of nuclei from living fibroblasts
of CTR (black symbols) and ADLD subjects (gray symbols). Each symbol represents the average stiffness  sd of 1 cell
nucleus. F) Box plot of average nuclear stiffness values of living CTR and ADLD fibroblasts. A total of 51 nuclei from living
CTR (n25) and ADLD (n26) fibroblasts were probed in 4 independent experimental sessions. **P  0.01,
Mann-Whitney rank sum test.
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similar effect. In N2a neuronal cells, transient LB1
overexpression increased nuclear stiffness of isolated,
FACS-sorted nuclei (mean stiffness of LB1/EGFP,
2.280.60 mN/m; EGFP alone, 1.190.30 mN/m;
P0.01, Mann-Whitney rank sum test) and in living
adherent cells (Fig. 5B). The levels of the cognate
proteins LA/C were not changed by LB1 overexpres-
sion in both HEK293 and N2a cells (Figs. 4A, 5A).
These results support the hypothesis that LB1 is directly
involved in increasing the nuclear rigidity associated
with ADLD.
To investigate whether the increased nuclear stiffness
in ADLD fibroblasts was specifically due to LB1 overex-
pression, we knocked down LB1 in these cells and
examined nuclear rigidity. To silence LB1 we trans-
fected a mixture of 2 plasmids bearing different LB1
shRNA sequences (23, 24) or a scrambled RNA plasmid
by amaxa nucleofection. Both the shRNA and scram-
bled plasmids also contained the cDNA for the EGFP
reporter. To confirm the knockdown, lamin protein
levels were determined in EGFP-positive cells selected
by FACS 72 h after transfection (Fig. 6A). LB1 levels
were reduced by 54% in cells transfected with LB1
shRNA compared with samples transfected with scram-
bled shRNA: the LB1/actin ratio after transfection with
the scrambled plasmid was 0.88 0.02 and was reduced
by LB1 shRNA to 0.39 0.06 (P0.01, Student’s t test).
The levels of cognate lamins were unaltered (LB2/
actin ratio for scrambled, 0.800.04, for LB1 shRNA,
0.790.01; LA/actin ratio for scrambled, 0.440.08,
for LB1 shRNA, 0.360.09; LC/actin ratio for scram-
bled, 0.520.01, for LB1 shRNA, 0.400.05; n.s., Stu-
dent’s t test).
We then measured the stiffness of nuclei with AFM
indentation. Nuclei from ADLD fibroblasts transfected
with scrambled RNA had the same stiffness as untrans-
fected cells (mean stiffness of ADLD plus scrambled,
1.420.16 mN/m, n27; ADLD untransfected, 1.18
0.10 mN/m, n55; P0.14 Mann-Whitney rank sum
test). However, LB1 silencing significantly reduced the
rigidity of ADLD nuclei (Fig. 6B), restoring them to
levels indistinguishable from CTR nuclei (ADLD si-
lenced, 1.010.13 mN/m, n24; CTR untransfected,
0.830.08 mN/m, n42; P0.19, Mann-Whitney rank
sum test). This indicates that the increased stiffness of
ADLD nuclei is specifically linked to LB1 overexpres-
sion.
Figure 6. LB1 knockdown reduced the nuclear stiffness of
ADLD fibroblasts. AFM nuclear stiffness analysis of ADLD
fibroblast nuclei following LB1 silencing with LB1 shRNA/
EGFP plasmid (SIL) or transfection with scrambled shRNA/
EGFP (Scr). A) Representative Western blots of LB1, LB2,
LA/C, EGFP, and actin in total lysates of HEK293 cells 48 h
following transfection of SIL or Scr plasmids. LB1 shRNA
reduced LB1 expression without altering the levels of cognate
lamins. B) Box plot of average nuclear stiffness of ADLD
fibroblasts on LB1 silencing. A total of 51 nuclei from EGFP
expressing cells (SIL, n27; Scr, n24) were analyzed in 2
independent experimental sessions. *P  0.05, Mann-Whit-
ney rank sum test.
Figure 4. Transient LB1 overexpression increased nuclear
stiffness in HEK293 cells. AFM nuclear stiffness analysis of
nuclei isolated from HEK293 cells expressing both LB1 and
EGFP or EGFP alone. A) Representative Western blots of LB1,
LA/C, EGFP, and actin in total lysates from cells transiently
overexpressing both LB1 and EGFP or EGFP alone. B) Box
plot of average nuclear stiffness of HEK293 cells overexpress-
ing both LB1 and EGFP or EGFP alone. A total of 39 nuclei
from cells expressing LB1/EGFP (n23) or EGFP alone
(n16) were analyzed in 4 independent experimental ses-
sions. **P  0.01, Mann-Whitney rank sum test.
Figure 5. Transient LB1 overexpression increased nuclear
stiffness in living N2a neuronal cells. AFM nuclear stiffness
analysis in living N2a neuronal cells expressing both LB1 and
EGFP or EGFP alone. A) Representative Western blots of LB1,
LA/C, EGFP, and actin in total lysates from cells transiently
overexpressing both LB1 and EGFP or EGFP alone. B) Box
plot of average nuclear stiffness of N2a cells overexpressing
both LB1 and EGFP or EGFP alone. A total of 38 living N2a
cells expressing LB1/EGFP (n21) or EGFP alone (n17)
was analyzed in 4 independent experimental sessions. *P 
0.05, Mann-Whitney rank sum test.
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Consistent with previous findings (14), the nuclear
rigidity of LB1-null MEFs (LB1/) (20) was similar to
wild-type MEFs (Supplemental Fig. S4B), indicating
that removal of LB1 alone does not reduce nuclear
stiffness below CTR values.
LB1 overexpression does not affect nuclear protein
localization in ADLD fibroblasts
To evaluate whether LB1 overexpression affects nu-
clear architecture and increases nuclear stiffness by
regulating protein localization, we analyzed the expres-
sion and localization of key nuclear proteins in CTR
and ADLD fibroblasts by immunohistochemistry. These
included nuclear proteins, such as the splicing factor
sc-35, the nucleolar protein fibrillarin, chromatin-asso-
ciated trimethyl histone H3, nuclear pore complexes,
and the LB1-interacting proteins Nup153 and LAP2.
In our experimental conditions, although there was an
increased proportion of misshapen nuclei (Supplemen-
tal Fig. S3B) in ADLD fibroblasts and increased LB1
levels (LB1 immunoreactive area/DNA stained area
ratio, CTR 84.95.9; ADLD 185.010.8; P0.01), we
did not observe any gross abnormalities of the localiza-
tion and levels of sc-35 (Fig. 7A, B), fibrillarin (Fig. 7C,
D), LAP2 (Fig. 7E-F), trimethyl histone H3 (Fig. 7G,
H), and nucleoporins (Fig. 7I, J). Furthermore, we did
not detect any significant differences in the proportion
of nuclei with activated RNA polymerase II (percentage
of nuclei immunoreactive for RNA polymerase II in
CTR, 26.172.60%, n767; in ADLD, 28.3312.42%,
n317; n.s., Student’s t test), consistent with overall
integrity of the LB1-dependent nucleoskeleton (46).
These data support the view that increased nuclear
stiffness in ADLD fibroblasts is not due to global
changes in nuclear protein localization.
LB1 overexpression in ADLD fibroblasts is associated
with altered nuclear ionic permeability
To evaluate whether the stiffness of ADLD nuclear
lamina has functional consequences on the ionic per-
meability of nuclei, we performed on-nucleus patch-
clamp experiments on isolated nuclei (41, 47). At
low-voltage stimuli, single channels were not evident in
either CTR or ADLD nuclei. To induce channel open-
ings independently of molecular cytosolic factors and
substrates, we challenged isolated nuclei with increas-
ing voltage steps, from 100 to 180 mV. Under these
conditions, we recorded channel opening in virtually
all trials. Single channel conductance was similar in
CTR and ADLD nuclei (average conductance of CTR,
753.4 pS; ADLD, 774.1 pS). However, the mean
open time was significantly different in CTR and ADLD
channels (Fig. 8). At all voltages applied, the mean
open probability (Po) in ADLD nuclei was lower than
in CTR nuclei [2-way ANOVA, genotype (F23.785;
P0.001); treatment (F19.541; P0.001); genotype	
treatment (F2.713; P0.05]), with statistically signifi-
cant differences at membrane potentials equal or
higher than 140 mV. The mean Po at 140 mV in CTR
nuclei was 0.38 0.10, in ADLD, 0.15 0.04 (P0.05);
at 160 mV in CTR, 0.55  0.13, in ADLD, 0.19  0.04
(P0.05); and at 180 mV in CTR, 0.64 0.14, in ADLD
0.34 0.07 (P0.05). Overall, these results suggest that
nuclear signaling through ion channels is inversely
proportional to nuclear rigidity in ADLD fibroblasts.
DISCUSSION
Here, we demonstrate that in primary skin fibroblasts
derived from patients with ADLD, LB1 is overex-
pressed. In these cells, the LB1 protein primarily local-
izes to the nuclear lamina and causes increased nuclear
stiffness. Transient overexpression of LB1 also in-
creases nuclear stiffness in HEK293 and N2a neuronal
cells, mimicking the ADLD nuclear phenotype. Nota-
bly, the expression of cognate lamins is unaltered in
ADLD fibroblasts or LB1-transfected cells, indicating
that the increased stiffness does not depend on these
other lamins. Moreover, shRNA silencing in ADLD
fibroblasts, which specifically reduces LB1 protein lev-
els, restores nuclear elasticity to levels that are indistin-
guishable from CTR cells, supporting the view that LB1
overexpression is directly linked to enhanced nuclear
rigidity. The increased stiffness of ADLD nuclei is
associated with a reduced open probability of nuclear
ion channels when voltage steps are applied, suggesting
that LB1-driven changes in nuclear mechanics may
functionally affect nuclear ionic signaling.
Our findings support the idea that lamin mutations
or altered lamin expression significantly affect the
elastic properties of the nuclear lamina. A- and B-type
lamins form distinct, but interacting, stable networks in
the lamina (24) and play distinct roles in defining the
nuclear architecture and mechanics (14). Indeed, un-
der biaxial strain, LA/C-deficient MEFs exhibit in-
creased numbers of misshapen nuclei, increased nu-
clear deformation, and decreased cell viability (14). In
contrast, while it does alter nuclear morphology, LB1
deficiency does not affect nuclear deformability in
MEFs (14). Consistently, we found that the nuclear
stiffness of LB1-null MEFs is not significantly different
from that of wild-type MEFs. It is possible that the
impact of LB1 deficiency could be masked by redun-
dant roles of LB2, which is normally expressed in
LB1-null MEFs (48). Alternatively, based on previous
findings (14), we can postulate that, in cells expressing
both A- and B-type lamins, LA is the principal determi-
nant of nuclear deformability. Nonetheless, at constant
levels of cognate lamins, LB1 overexpression increases
the number of misshapen nuclei (Supplemetnal Fig.
S3B) and significantly increases nuclear stiffness, indi-
cating that LB1 protein over-dosage plays a key role in
defining the biophysical properties of the nuclear lam-
ina.
In agreement with previous evidence that cell me-
chanical properties vary during the cell cycle (33), we
found that nuclear stiffness varies according to the
proliferation state of cells: it is significantly higher in
proliferating than quiescent fibroblasts. However, the
LB1-induced increased stiffness is independent of cell
proliferative state: AFM indentation measurements on
nuclei from human fibroblasts in a quiescent state rule
out a confounding effect of cell proliferation. More-
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over, although there is substantial variation among
fibroblasts obtained from different donors, the average
proliferative rates and the ability to enter quiescence
with serum withdrawal are similar in ADLD and CTR
fibroblasts. This contrasts with previous evidence that
altered LB1 protein levels may affect cell proliferation.
In fact, it has been shown that LB1 overexpression both
decreases (43) and increases (23) the proliferation of
human fibroblasts of dermal or embryonic lung origin,
respectively. Several factors may contribute to these
Figure 7. Localization and ex-
pression of selected nuclear pro-
teins were unaltered in ADLD
fibroblasts. A, C, E, G, I) Re-
presentative maximal projections
of z-stack confocal images of nu-
clei from CTR and ADLD human
skin fibroblasts immunoreactive
for sc-35 (green; A), fibrillarin
(red; C), LAP2 (E), trimethyl-
histone-H3(Lys 27) (G), nuclear
pore complex (I), and LB1 (red,
I). In A and C, nuclear DNA is
counterstained with Hoechst-
33342 (blue). Scale bars  5 m.
B, D, F) Quantification of sc-35
(B), fibrillarin (D), and LAP2
() immunoreactive area normal-
ized on area of DNA staining with
Hoechst-33342. H, J) Quantifica-
tion of protein expression levels
of trimethyl-histone-H3(Lys 27)
(H) and nucleoporin Nup98 (J)
by Western blot analysis. Values
are normalized on -tubulin exp-
ression.
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divergent results, including developmental stage (em-
bryonic vs. adult), tissue of origin (lung vs. skin), aging
in vitro, transient overexpression of the protein, and/or
interactions with the genetic background of distinct
donors. In our study, we compared primary human skin
fibroblasts derived from different adult donor patients
or age-matched CTR subjects, while studies from other
groups (23, 43) experimentally manipulated LB1 levels
in cells with uniform genetic backgrounds (e.g., WI-38
cells). In view of the complex regulation of cell prolif-
eration, it is possible that individual genetic variables
may have masked the specific effects of LB1 in our
study.
The mechanisms by which excess LB1 causes ADLD
pathology are unclear. One hypothesis is that LB1
overexpression could affect nuclear protein organiza-
tion, increasing the stiffness of nuclei as a consequence
of chromatin and protein relocalization. However, our
results do not support this idea. Although the propor-
tion of misshapen nuclei in ADLD fibroblasts is in-
creased, we did not observe any gross abnormalities of
nuclear architecture based on the localization of nu-
clear proteins, including sc-35, fibrillarin, histone H3,
LAP2 and nucleoporins, or chromatin, as detected by
Hoechst 33342 DNA staining and electron microscopy.
Our findings differ from those of a previous study,
which reported that the transfection of LB1 in cell lines
of neurons, astrocytes, and oligodendrocytes leads to
severe abnormalities of nuclear morphology and al-
tered LAP2 levels and localization (49). The use of
primary human skin fibroblast cultures vs. transiently
transfected cell lines may account for this discrepancy.
Indeed, the protein expression achieved by transient
transfection in cell lines may be severalfold higher than
physiological levels. In contrast, LB1 overexpression in
primary human fibroblasts of patients with ADLD is
mild (i.e., 1.5 to 2-fold increase) and may translate into
only subtle changes in the localization or activation of
signaling molecules.
An alternate model is that the LB1-induced increase
in nuclear rigidity may alter cells’ nuclear signaling (for
a review, see refs. 50, 51). The nucleus, because of its
mechanical properties and interconnections with the
cytoskeleton, can act as a mechanosensor of internal
and external forces, converting these signals into bio-
logical responses by activating gene expression (52,
53). Consistent with this, disrupting the nuclear lamina
results in nuclear abnormalities and altered mechano-
transduction signaling. Indeed, in LA-deficient MEFs
(48), the mechanical activation of NF-B is compro-
mised, and cells lacking emerin or LA have reduced
expression of mechanosensitive genes (48, 54). Our
results support this link between ADLD and improper
nuclear signal transduction and further suggest that
signaling defects depend on nuclear ion channel func-
tion. We recently reported that in ADLD fibroblasts
Oct1 recruitment to the nuclear periphery is increased
and its mobilization in response to oxidative stress is
reduced (55). In nuclei isolated from ADLD cells,
channel openings induced by biophysical challenge
(i.e., voltage steps on isolated nuclei, in the absence of
molecular cytosolic factors and substrates) are reduced,
supporting the view that altered mechanical properties
of the nuclear lamina may translate into functional
changes in nuclear signaling. This is consistent with
findings demonstrating that, in osteoblasts (56) and
HEK293 cells (57), membrane strain and tension affect
the open probability of mechanosensitive ion channels.
While these results implicate nuclear signaling in
ADLD, further experiments are needed to identify the
specific mechanisms of altered nuclear ionic permea-
bility that are affected by LB1-induced nuclear rigidity.
Notably, LB1 protein levels also modulate nuclear
rigidity in neuronal N2a cells. This is specifically rele-
vant for the pathogenesis of ADLD, which affects the
central nervous system. There is some evidence that
mechanical forces and neuronal function are linked
(58). For example, in primary hippocampal neurons,
nuclear geometry is dynamically regulated by neuronal
activity and death signals, which modulates nuclear
infolding and nuclear calcium transients in opposite
directions (59). Nuclear calcium is the signal that
switches on the gene expression required for the long-
term implementation of brain functions, such as learn-
ing and memory, and adaptive responses of the nervous
system, such as activity-dependent neuron survival and
neural repair after injury (60). Given this scenario and
the evidence that ADLD fibroblasts have an increased
number of misshapen nuclei, we postulate that changes
in nuclear stiffness in neurons may alter their nuclear
geometry, thus affecting neuronal survival and function
in ADLD.
In conclusion, our findings reveal a previously unrec-
ognized function of LB1 in controlling the mechanical
properties of cell nuclei. LB1 overexpression alters
nuclear stiffness in human somatic cells, possibly lead-
Figure 8. Nuclear ionic permeability was altered in ADLD
fibroblasts. Single-channel recordings in isolated nuclei. A–D)
Selected traces of nucleus-attached single-channel activity in
isolated nuclei from CTR (A, C) and ADLD (B, D) fibroblasts
challenged with 100 mV (A, B) and 140 mV (C, D) test
potentials. E, F) Channel open probability. The channel open
probability in CTR nuclei (E) increased from 0.02  0.005 at
100 mV to 0.64  0.14 at 180 mV (n7). In ADLD nuclei (F),
the channel open probability displayed a normalized value of
0.009  0.004 at 100 mV and 0.34  0.07 at 180 mV (n9).
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ing to changes in ionic signaling in ADLD cells. In
ADLD fibroblasts, LB1 knockdown restores nuclear
elasticity to physiological levels, suggesting that regulat-
ing LB1 expression may represent a target for the
discovery of therapies for ADLD. Further investigation
is required to elucidate precisely how LB1 overexpres-
sion affects neuronal nuclear signaling and drives cere-
bral pathogenic cascades in ADLD.
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